Delve into the new era of genome sequencing- MarketsandMarkets Advanced Genetic Sequencing Virtual Conference

Delve into the new era of genome sequencing- MarketsandMarkets Advanced Genetic Sequencing Virtual Conference

July 12th, 2021- Genome sequencing is providing physicians with more data about the causes of cancer and changing the way some forms of the disease are treated. Continued advancements in sequencing technologies have fuelled the development of new sequencing applications. MarketsandMarkets is proud to announce the first edition of Advanced Genetic Sequencing Virtual Conference scheduled to be held on 23rd & 24th of September 2021. A 2-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology…

Read More

Embracing next-generation technologies for new-age digitization- MarketsandMarkets Plant Digitization Virtual Conference 2021

Embracing next-generation technologies for new-age digitization- MarketsandMarkets Plant Digitization Virtual Conference 2021

July 08th, 2021- Digitization – through SMART TECHNOLOGIES and CONNECTED DEVICES- is increasing PRODUCTIVITY, EFFICENCY AND ACCURACY in manufacturing and process-based enterprises. Industry experts believe, in future virtually all plant operations will be converted into a digital format.  We, along with HIMA as our co-sponsor, are proud to present you the APAC edition of MarketsandMarkets Plant Digitization Virtual Conference which is scheduled to take place on 19th – 20th August 2021. The 2-day conference will extend the opportunity to explore the technological advances and innovations in the field of Plant…

Read More

Discussing the latest IO developments at the 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Virtual Congress 2021

Discussing the latest IO developments at the 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Virtual Congress 2021

July, 08th 2021 – 5th Annual MarketsandMarkets Next-Gen Immuno-Oncology Virtual Congress 2021 to be held on the 26th-29th October 2021 will host top tier institutes pharmaceutical, bio-pharmaceutical and biotechnology companies like Scancell, Regeneron Pharmaceuticals, Cancer Vaccines Ltd, Boston Immune Technologies & Therapeutics & more to deliver the key challenges and future directions in IO research and to discuss the latest updates in development of ADC’s, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors    The conference aims to bring together 25+ industry thought leaders & 200+ attendees from pharmaceutical and…

Read More

“Tumor-targeted costimulatory trimerbodies for cancer immunotherapy.”- A brief discussion with Juan Perez Villar, CEO, LeadArtis.

“Tumor-targeted costimulatory trimerbodies for cancer immunotherapy.”-  A brief discussion with Juan Perez Villar, CEO, LeadArtis.

Doctor in Immunology from the Autonomous University of Madrid (Spain), extensive international career in the biopharmaceutical industry at Astellas Inc. and Bristol-Myers Squibb Co. (USA). Experienced R&D leader in immune-oncology (IO). Previously, participated in preclinical development of CD28 biologic modulators for inflammatory conditions, small molecule tyrosine kinase inhibitors and fully human antibodies for advanced solid tumors at Leadartis. He advanced the company from start to capitalize on the immuno-oncology (IO) market. Evaluated and repositioned the platform technology to create IO bispecific antibody dominance and created a proprietary next generation product…

Read More

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

Héctor Pérez Montoyo, of Ability Pharma discusses his research on, “ABTL0812, a new immunotherapeutic anticancer agent at phase 2b clinical stage.”

Héctor’s work has always focused on understanding the molecular pathophysiological mechanisms leading to autoimmunity and cancer development, investigating mechanism of action of newly developed molecules to treat such diseases. He started his career in 2006 when he moved to UT Southwestern Medical Center in Dallas (EEUU), to carry out this thesis in developing novel therapeutic antibodies in murine models of human autoimmune diseases. After obtaining his Ph.D., he combined two postdoctoral grants in Barcelona (Metastasis and Transformation group in Bellvitge Biomedical Research Center) and in Valencia (Autoimmune Pathology Lab in…

Read More

Dr. William Williams of Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

Dr. William Williams of  Briacell Therapeutics Corporation talks about Personalized, off-the-shelf cellular immunotherapy for cancer

Dr. Williams is the President and CEO of BriaCell Corporation, where he has shepherded Bria-IMT™ into the clinic, established positive proof-of-concept, forged a collaboration with Incyte for novel combinations and coordinated the development of an off-the-shelf personalized approach to cancer immunotherapy. While at Incyte Corporation as Head of Exploratory Development, he brought numerous molecules into the clinic and established proof of concept in several disease areas. At GlaxoSmithKline he worked to bring several molecules into the clinic, ran a biomarker laboratory and spearheaded initiatives to utilize emerging technologies in drug…

Read More

Discussing the Top 10 Opportunities in Robotics at the MarketsandMarkets Robotics CRYSTAL BALL EVENT!

Discussing the Top 10 Opportunities in Robotics at the MarketsandMarkets Robotics CRYSTAL BALL EVENT!

February 24th – MarketsandMarkets Robotics CRYSTAL BALL EVENT on the March 9, 2021 will host industry giants Softbank Robotics America, 6 River Systems, Fetch Robotics and Denso to present their thoughts on the Top 10 Opportunities in Robotics in the next 5 year!  The MarketsandMarkets Robotics CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Innoviz Technologies, Travelport, GM Modular Pvt. Ltd, Venture Talent Solutions, Unipac, Movandi Corp, Sirius Unbound, Shindengen America, Inc., Konica Minolta Business Solutions, Raymond James, University of Waterloo, National Grid, Polyexplore, Owl Cyber Defense, Polpharma, Advantech, New Normal Digital Inc., AiGraphics, Persistent, Microchip, Amazon.com, Cabrzill Pvt Ltd, Invesco, Freepoint, Gen II Fund Services, LLC, Uchimura Robotics LLC, SpotOn, Akzonobel, Owens Design, B2Holding ASA, etc.  A host of attractive, high growth opportunities such as Smart Factory, Precision Agriculture, Last Mile Delivery, Warehouse Automation, Cooperative & Network Robotics, Entertainment Robotics,…

Read More

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

Discussing Top 10 Disruptions in BioPharma Manufacturing at the MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT!

February 26th – MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT on the March 11, 2021 will hostindustry giants Fresenius Kabi, Charles River Laboratories, GenScript ProBio, Pall Corporation and MilliporeSigma to present their thoughts on the Top 10 Disruptions Through BioPharma Manufacturing in the next 5 year! MarketsandMarkets BioPharma Manufacturing CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as Biocon Biologics, Ology Bioservices, Celonic AG, Gyroscope Therapeutics, GenIbet, Hemobras, H2i Group, MilliporeSigma, Orange Grove Bio, HORIBA, Porex Life Sciences Institute, Kaneka, Lonza, Cytiva, GEA North America, Batavia Biosciences, Nova…

Read More

Discussing Top 10 Disruptions Through Artificial Intelligence at the MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT!

Discussing Top 10 Disruptions Through Artificial Intelligence at the MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT!

February 26th – MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT on the March 10, 2021 will hostindustry giants Google, IBM Global Markets, Avaya International and Intellio to present their thoughts on the Top 10 Disruptions Through Artificial Intelligence in the next 5 year! The MarketsandMarkets Artificial Intelligence CRYSTAL BALL EVENT will gather 100+ professionals from industry giants such as JUJU Solutions, Retlewski & Associates, Oracle, Harman South America, Microsoft, Arus, 3Insy,s VFS Ventures, c/o Architecture Technology Corp., ABB, Travelport, Coca-Cola European Partners, Polyexplore, RGA, Polpharma, Ricoh, SAS, vettd.ai, Advantech, Drexel, Persistent,…

Read More

Discussing “Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale “with Dr. Vania Silverio of INESC-MN, Portugal.

Discussing “Laboratory miniaturization hand in hand with Microfabrication and Nanotechnology – systems integration at the microscale “with Dr. Vania Silverio of INESC-MN, Portugal.

Dr. Vania Silverio is a Microfluidics architect with strong background in microengineering. She combines know-how in simulation, design and fabrication of micron-sized fluidic paths with the integration of sensing and actuation elements towards the miniaturization of laboratories. Dr. Silverio is the Leader of the Microfluidics group at INESC Microsystems and Nanotechnologies (INESC MN) providing modular microfluidic solutions. She is Invited Assistant Professor at the Physics Department of Instituto Superior Tecnico (IST), ULisboa where, among others, she is the responsible for the curricular course on Microfluidics, unique in Portugal. She supervises…

Read More